BAY-1436032

CAS: 1803274-65-8

Ref. 3D-DXC27465

Produktinformation

• Name: BAY-1436032

Beschreibung

BAY-1436032 is a novel small molecule inhibitor of CXCR4. It has been shown to be an effective treatment for cancer in vitro, with potent inhibition of cancer cell growth and anti-leukemic activity. BAY-1436032 is orally bioavailable and has good pharmacokinetic properties. It binds specifically to the CXCR4 receptor, blocking the binding of stromal cell-derived factor 1α (SDF1α) and its chemokine ligand 4 (CXCL4). This drug has also been shown to inhibit the proliferation of leukemia stem cells in vitro and in vivo, as well as suppressing sarcoma cell growth.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 489.53 g/mol
• Formel: C₂₆H₃₀F₃N₃O₃
• Reinheit: Min. 95%